Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAWP Inhibitors

Postacrosomal sheath WW domain-binding protein (PAWP), a sperm-specific protein located within the postacrosomal sheath of the sperm head, plays a critical role in the fertilization process, specifically in inducing oocyte activation and subsequent embryonic development. PAWP's function is predicated on its ability to trigger calcium oscillations within the oocyte upon fertilization, a process that is essential for the resumption of meiosis, pronuclear formation, and the initiation of embryogenesis. This mechanism is thought to mimic that of certain phospholipase C isoforms, suggesting a unique pathway by which sperm induces the activation of the oocyte. By acting as a signaling molecule, PAWP initiates a cascade of events that are crucial for the successful union of sperm and egg, making it a focal point for understanding fertilization at a molecular level.

The inhibition of PAWP's function, therefore, directly impacts fertilization efficacy by obstructing one of the initial steps in embryonic development. Mechanisms that inhibit PAWP can range from the interference of PAWP's binding to its oocyte receptors, the alteration of its structure through post-translational modifications, or the competitive inhibition by similar proteins or peptides that mimic its action but do not induce the same intracellular response. Furthermore, the regulation of PAWP's activity could involve the modulation of its expression levels in sperm, the alteration of its localization within the sperm, or the disruption of the downstream signaling pathways it activates within the oocyte. Such inhibition can provide insights into the complex interplay of proteins involved in fertilization and offer potential avenues for the study of fertility regulation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor, can interfere with protein kinase C, which may be upstream of WBP2NL.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K, potentially affecting pathways that are involved in the regulation of WBP2NL.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, which can have downstream effects on pathways involving WBP2NL.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that can alter signaling pathways, potentially affecting WBP2NL activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAP kinase, possibly influencing signaling pathways related to WBP2NL.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK, which can affect ERK pathway signaling and indirectly WBP2NL.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$199.00
$460.00
$1479.00
1
(0)

A potent Gs alpha subunit inhibitor, indirectly affecting signaling related to WBP2NL.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

A multi-kinase inhibitor, may affect various pathways including those involving WBP2NL.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

A calcium chelator, can interfere with calcium-dependent signaling pathways and WBP2NL.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor, can indirectly affect pathways associated with WBP2NL.